For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Less deemed dividend on subsidiary preferred stock attributable to the noncontrolling interests | 0 | 0 | - | 1,874* |
| Provision for income taxes | 0 | 0 | - | 0* |
| Revenue | 5 | 6 | 8 | 33* |
| Amortization of acquired intangible assets | 0 | 0 | - | 279* |
| Sales and marketing | 201 | 220 | 247 | 884* |
| General and administrative | 3,505 | 3,670 | 4,384 | 4,038* |
| Research and development | 1,088 | 790 | 787 | 1,158* |
| Cost of revenue | 55 | 41 | 36 | 270* |
| Total operating expenses | 4,849 | 4,721 | 5,454 | 6,627* |
| Operating loss | -4,844 | -4,715 | -5,446 | -6,594* |
| Loss on deconsolidation of subsidiary | 0 | - | - | -41,523* |
| Debt extinguishments gain - senior secured convertible notes | 0 | 0 | -58 | 714* |
| Debt modification expense | 0 | 0 | - | -500* |
| Interest income | 10 | 8 | 8 | -16* |
| Interest expense | 8 | 4 | 4 | 11* |
| Change in fair value - equity method investment | -4,382 | -10,643 | 21,004 | -689* |
| Change in fair value - senior secured convertible notes | 100 | 200 | 49 | -951* |
| Management fee income | 3,150 | 3,150 | 3,150 | 1,750* |
| Grant income | 163 | 80 | 18 | 27* |
| Other income (expense), net | -1,167 | -7,609 | 24,069 | -39,296* |
| Income (gain) before provision for income tax | -6,011 | -12,324 | 18,623 | -45,890* |
| Net income (gain) before noncontrolling interests | -6,011 | -12,324 | 18,623 | -45,890* |
| Net gain attributable to the noncontrolling interests | -628 | -403 | -345 | 299* |
| Net income (gain) attributable to pavmed inc | -5,383 | -11,921 | 18,968 | -46,189* |
| Less series b convertible preferred stock dividends earned | 90 | 88 | 86 | 83* |
| Less series c convertible preferred stock dividends earned | 470 | 481 | 398 | - |
| Less deemed dividend on series c convertible preferred stock | -385 | -818 | -789 | - |
| Net income (gain) attributable to pavmed inc. common stockholders | -6,328 | -13,308 | 17,695 | -48,146 |
| Basic EPS | -0.29 | -0.74 | 1.28 | -4.884 |
| Diluted EPS | -0.29 | -0.74 | 0.34 | -0.737 |
| Basic Average Shares | 21,554,546 | 18,084,653 | 13,876,165 | 9,858,399 |
| Diluted Average Shares | 21,554,546 | 18,084,653 | 52,496,401 | 65,291,623* |
PAVmed Inc. (PAVM)
PAVmed Inc. (PAVM)